Can we predict dangerous clots in this rare blood cancer?
NCT ID NCT05548062
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 26 times
Summary
This study watches 242 people with high-risk polycythemia vera, a blood condition that raises the risk of dangerous blood clots. Researchers track things like blood pressure, weight, and lab tests to see which factors best predict clots. The goal is to help doctors identify who is most at risk and prevent future events.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Alessandria, AL, 15121, Italy
-
Novartis Investigative Site
Ancona, AN, 60126, Italy
-
Novartis Investigative Site
Bari, BA, 70124, Italy
-
Novartis Investigative Site
Bologna, BO, 40138, Italy
-
Novartis Investigative Site
Como, CO, 22100, Italy
-
Novartis Investigative Site
Cosenza, CS, 87100, Italy
-
Novartis Investigative Site
Catania, CT, 95123, Italy
-
Novartis Investigative Site
Florence, FI, 50134, Italy
-
Novartis Investigative Site
Genova, GE, 16132, Italy
-
Novartis Investigative Site
Lecce, LE, 73100, Italy
-
Novartis Investigative Site
Tricase, LE, 73039, Italy
-
Novartis Investigative Site
Monza, MB, 20900, Italy
-
Novartis Investigative Site
Milan, MI, 20122, Italy
-
Novartis Investigative Site
Palermo, PA, 90127, Italy
-
Novartis Investigative Site
Palermo, PA, 90146, Italy
-
Novartis Investigative Site
Piacenza, PC, 29100, Italy
-
Novartis Investigative Site
Padova, PD, 35100, Italy
-
Novartis Investigative Site
Padova, PD, 35128, Italy
-
Novartis Investigative Site
Pisa, PI, 56124, Italy
-
Novartis Investigative Site
Parma, PR, 43126, Italy
-
Novartis Investigative Site
Reggio Calabria, RC, 89100, Italy
-
Novartis Investigative Site
Reggio Emilia, RE, 42123, Italy
-
Novartis Investigative Site
Roma, RM, 00161, Italy
-
Novartis Investigative Site
Roma, RM, 00168, Italy
-
Novartis Investigative Site
Roma, RM, 00189, Italy
-
Novartis Investigative Site
Pagani, SA, 84016, Italy
-
Novartis Investigative Site
Orbassano, TO, 10043, Italy
-
Novartis Investigative Site
Torino, TO, 10126, Italy
-
Novartis Investigative Site
Terni, TR, 05100, Italy
-
Novartis Investigative Site
Varese, VA, 21100, Italy
-
Novartis Investigative Site
Vicenza, VI, 36100, Italy
-
Novartis Investigative Site
Verona, VR, 37134, Italy
-
Novartis Investigative Site
Viterbo, VT, 01033, Italy
-
Novartis Investigative Site
Naples, 80131, Italy
-
Novartis Investigative Site
Naples, 80132, Italy
Conditions
Explore the condition pages connected to this study.